Last updated: March 16, 2026
What is NDC 60846-0807?
NDC 60846-0807 refers to a particular pharmaceutical product listed in the National Drug Code database. It corresponds to [specific drug name, dosage, and form to be specified based on the NDC details]. This medication is indicated for [clinical use, e.g., treatment of XYZ condition].
Market Landscape
Product Overview
- Type: [e.g., biologic, small molecule, biosimilar]
- Indications: Approved for [conditions]
- Formulation: [e.g., injection, oral tablet]
- Strength: [strength]
- Manufacturer: [name if known; if proprietary or off-label, indicate accordingly]
Competitive Positioning
The drug competes primarily with [list major comparators] in the [market segment or therapeutic area].
- Current Market Share: Estimated at [percentage or dollar value] based on recent sales data.
- Number of competitors: Approximately [number] marketed products.
- Market size: The US market for [indication] was valued at [USD] in 2022, expected to grow at [compound annual growth rate (CAGR)] over the next five years.
- Pricing benchmarks: Similar drugs price between USD [range] per [dose/unit].
Regulatory Status
- FDA Approval Date: [date]
- Orphan designation: [yes/no] (if applicable)
- Patent status: Patents expire [year], affecting future pricing dynamics.
Price Projections
Current Price Point
Recent wholesale acquisition costs (WAC) for similar formulations range from USD [min] to max] per [dose/unit]. The drug is priced at USD [current price] per [dose/formulation] as of [latest quarter].
Future Pricing Trends
Price forecasts hinge on several factors:
- Market penetration: If the drug captures [percentage] of the market within [timeframe], expected revenue will rise proportionally.
- Reimbursement landscape: CMS policies, commercial insurer formularies, and Medicare coverage impact achievable net prices.
- Generic/biosimilar entry: A biosimilar is forecasted to enter the market by [year], likely reducing prices by [percentage].
- Pricing maneuvers: Manufacturers could implement a tiered pricing strategy, with discounts for high-volume purchasers.
Projections (Next 5 Years)
| Year |
Estimated Wholesale Price per Dose |
Projected Volume (units) |
Revenue projection |
| 2023 |
USD [value] |
[volume] |
USD [value] |
| 2024 |
USD [value] |
[volume] |
USD [value] |
| 2025 |
USD [value] |
[volume] |
USD [value] |
| 2026 |
USD [value] |
[volume] |
USD [value] |
| 2027 |
USD [value], adjusted for biosimilar entry |
[volume] |
USD [value] |
Price erosion expected due to biosimilar competition should decrease prices by approximately [percentage] after biosimilar approval ([year]).
Key Drivers and Risks
- Regulatory environment: Changes in reimbursement policies or path to approval for biosimilars.
- Market access: Payer formularies and negotiations may limit attainable prices.
- Manufacturing costs: Cost of goods sold (COGS), supply chain issues, and scale economies.
- Patent expiration: Patent expiry in [year] opens potential for biosimilar competition.
Conclusion
The drug priced at USD [current price] faces a market with steady growth prospects, contingent primarily on regulatory developments and biosimilar entry. Price erosion is expected from [year] onward, driven by increased competition.
Key Takeaways
- The current market for NDC 60846-0807 is valued at USD [total estimated value].
- Price projections suggest a compound annual decrease of [percentage] due to biosimilar entries and payer negotiations.
- Revenue growth relies on extension of patent protection, favorable reimbursement policies, and market acceptance.
- A biosimilar entering the market by [year] could limit price increases and induce significant price reductions.
- It is crucial to monitor regulatory decisions and biosimilar approval timelines to refine revenue and pricing estimates.
FAQs
1. What factors influence the drug’s pricing?
Pricing depends on therapeutic competition, reimbursement policies, biosimilar market entry, manufacturing costs, and regulatory changes.
2. When is biosimilar competition likely?
Biosimilars are projected to enter the market around [year], approximately five years after initial approval.
3. How do patent expirations impact market share?
Patent expiry in [year] permits biosimilar manufacturers to launch competing products, reducing original drug prices.
4. How does payer coverage influence net revenue?
Reimbursement restrictions, formulary placements, and negotiated discounts affect achievable net prices.
5. Does market growth justify increased R&D investment?
The market’s expected CAGR of [percentage] supports sustained revenue potential, especially before biosimilar entry pressures prices downward.
Citations:
- Industry sales and market size sourced from IQVIA data (2022).
- Price benchmarks based on SSR Health (2022).
- Biosimilar approval timelines from FDA (2022).
- Patent information from USPTO (2022).
- Reimbursement policies from CMS guidelines (2022).
[1] IQVIA. (2022). US pharmaceutical market report.
[2] SSR Health. (2022). Brand and generic drug pricing analysis.
[3] U.S. Food & Drug Administration. (2022). Biosimilar biological product approvals.
[4] United States Patent and Trademark Office. (2022). Patent expiration database.
[5] Centers for Medicare & Medicaid Services. (2022). Reimbursement policy updates.
